References
- Klein R S, Harris C A, Smell C B, Moll B, Lesser M, Friedland G H. Oral candidiasis in high-risk patients as the initial manifestation of acquired immunodeficiency syndrome. N Engl J Med 1984; 9: 354–357
- Wheat L J, Slama T G, Norton J A, Kohler R B, Eitzen H E, French M LV, Sathapatayavongs B. Risk factors for disseminated or fatal histoplasmosis. Ann Intern Med 1982; 96: 159–163
- CDC Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: 15–155
- Pathology of tropical and extraordinary diseases, C H Binford, D H Connor. Armed Forces Institute of Pathology, An atlas. Washington D.C. 1976; 289
- Bonner J R, Alexander W J, Dismukes W E, App W, Griffin F M, Little R, Shin M S. Disseminated histoplasmosis in patients with the acquired immune deficiency syndrome. Arch Intern Med 1984; 144: 2178–2181
- Taylor M N, Baddour L M, Alexander J R. Disseminated histoplasmosis associated with the acquired immune deficiency syndrome. Am J Med 1984; 77: 579–580
- Wheat L J, Slama T G, Zeckel M L. Histoplasmosis in the acquired immune deficiency syndrome. Am J Med 1985; 78: 203–210
- Mandell W, Goldberg D M, Neu H C. Histplasmosis in patients with the acquired immune deficiency syndrome. Am J Med 1986; 81: 974–978
- Huang C T, McGarry T, Cooper S, Saunders R, Andavolu R. Disseminated histoplasmosis in the acquired immunodeficiency syndrome. Arch Intern Med 1987; 147: 1181–1184
- Salzman S H, Smith R L, Aranda C P. Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest 1988; 93: 916–921
- Holmberg K, Meyer R D. Fungal infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis 1986; 18: 179–192
- Payan D G, Wheat L J, Brahmi Z, Stephen I P, Hansen W P, Hoffmann R A, Healey K, Rubin R H. Changes in immunoregulatory lymphocyte populations in patients with histoplasmosis. J Clin Immunol 1984; 4: 98–107
- Johnson P C, Khardori N, Majjar A F, Butt F, Mansell P WA, Sarosi G. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 152–158
- Wheat J, French M LV, Kohler R B, Zimmerman S E, Smith W RS, Norton J A, Eitzen H E, Smith C D, Slama T G. The diagnostic laboratory tests for histoplasmosis. Ann Intern Med 1982; 97: 680–685
- Paya C V, Roberts G D, Cockerill F R, III. Laboratory methods for the diagnosis of disseminated histoplasmosis: Clinical importance of the lysis-centrifugation blood culture technique. Mayo Clin Proc 1987; 62: 480–485
- Slama T G. Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. Am J Med 1983; 74: 70–73, Suppl. IB
- Wheat L J. Ketoconazole therapy for AIDS patients with disseminated histoplasmosis. Arch Intern Med 1985; 145: 2272
- Glatt A S, Chirgwin K, Landesman S H. Treatment of infections associated with human immunodeficiency virus. N Engl J Med 1988; 318: 1439–1448
- Dismukes W E. Azole antifungal drugs. Old and new. Ann Intern Med 1988; 109: 177–179
- Graybill J R. Fluconazole efficacy in animal models of mycotic diseases. Trends in the discovery, development and evaluation of antifungal agents, R A Fromtling. JR Prous Science Publishers. 1987